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Abstract
Aims Smoking is a major risk factor for cardiovascular complications among patients with diabetes. Hospitalization has
been shown to enhance cessation rates. The purpose of this study was to compare 6-month post-hospitalization tobacco
cessation rates among US veterans with and without diabetes.
Methods This was a longitudinal study among inpatient veterans who used tobacco in the past month (n = 496). Patients
were recruited and surveyed from three Midwestern Department of Veterans Affairs hospitals during an acute-care hospi-
talization. They were also asked to complete a follow-up survey 6 months post-discharge. Bivariate- and multivariable-
adjusted analyses were conducted to determine differences in tobacco cessation rates between patients with and without a
diagnosis of diabetes.
Results The mean age of patients was 55.2 years and 62% were white. Twenty-nine per cent had co-morbid diabetes. A
total of 18.8% of patients with diabetes reported tobacco cessation at 6 months compared with 10.9% of those without
diabetes (P = 0.02). Cotinine-verified cessation rates were 12.5 vs. 7.4% in the groups with and without diabetes, respec-
tively (P = 0.07). Controlling for psychiatric co-morbidities, depressive symptoms, age, self-rated health and nicotine
dependence, the multivariable-adjusted logistic regression showed that patients with diabetes had three times higher odds of
6-month cotinine-verified tobacco cessation as compared with those without diabetes (odds ratio 3.17, P = 0.005).
Conclusions Post-hospitalization rates of smoking cessation are high among those with diabetes. Intensive tobacco
cessation programmes may increase these cessation rates further.
Diabet. Med. 29, e96–e101 (2012)
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Introduction
Diabetes affects 20%, or 1 million, of US Department of
Veterans Affairs users compared with 8% of the general pop-
ulation [1]. Diabetes accounts for 28% of Department of
Veterans Affairs pharmacy costs and Department of Veterans
Affairs patients with diabetes die at almost twice the rate as
veterans without diabetes [1]. Overall, 24% of adults with
diabetes smoke; this prevalence is similar to the rate among
those without diabetes [2,3], and smoking among those ser-
viced by the Department of Veterans Affairs is also approxi-
mately 20% [4].
Among people with diabetes, smoking is associated with
poor glycaemic control [5] and exacerbates macro- and
microvascular complications, including neuropathy, nephrop-
athy, retinopathy, cardiovascular disease and stroke [6].
Moreover, compared with non-smokers with diabetes, smokers
with diabetes were less likely to be active in diabetes care,
including self-checking blood glucose levels, doing exercise
and receiving medical services, and were more likely to feel
depressed and lack of social support from their family and
friends [7]. Thus, smokers with diabetes show increased
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morbidity and mortality rates. However, smoking cessation is
the most important strategy to reduce the complications among
patients with diabetes [7].
As rates of diabetes are particularly high in the Department of
Veterans Affairs, and as smoking is particularly harmful among
people with diabetes, having diabetes may serve as an additional
motivation to stop smoking among hospitalized Department of
Veterans Affairs patients. Hospitalization for a serious chronic
illness such as diabetes may prompt an emotional reaction,
increasing motivation to change behaviour [8], often called a
‘teachable moment’ [9]. Several studies have shown that hos-
pitalization itself appears to enhance cessation [10], as many
smokers have already achieved a period of abstinence as a result
of indoor smoking bans. However, inpatient smoking cessation
post-hospitalization has focused mainly on patients with
cardiovascular and pulmonary disease and has not been
extensively studied on inpatients with diabetes [11].
Prior to implementing a tobacco cessation programme for
inpatients, the objective of this study was to determine post-
hospitalization pre-intervention cessation rates among Depart-
ment of Veterans Affairs smokers with and without diabetes.
Given the well-known harmful effects of smoking on diabetes,
it is hypothesized that having diabetes may serve as an
additional motivation to stop smoking among hospitalized
Department of Veterans Affairs patients. Given the high
prevalence of diabetes and smoking in the Department of
Veterans Affairs, information about differential cessation rates
among smokers with and without diabetes may inform
smoking cessation interventions and other policies designed to
help patients stop smoking. In addition to informing Depart-
ment of Veterans Affairs national policies regarding smoking
cessation interventions for people with diabetes, the results of
this study have broad implications for understanding how
cessation programmes can take advantage of the teachable
moments afforded by a diabetes-related hospitalization.
Research design and methods
Design
This was a longitudinal study among patients that used tobacco
and were hospitalized at one of three Midwestern Department
of Veterans Affairs hospitals. The independent variable was
having a diagnosis of diabetes vs. not having a diagnosis of
diabetes. The dependent variables included 6-month tobacco
cessation rates. Multivariable analyses were adjusted for
co-morbid psychiatric problems, age, nicotine dependence,
depressive symptoms and self-rated health. Human studies
approval was received from all of the sites included in the study
and informed consent was obtained from all patients.
Setting and sample
Patients were recruited at the time of admission to Department
of Veterans Affairs hospitals in Ann Arbor and Detroit,
Michigan, and Indianapolis, Indiana. Patients were eligible if
they: (1) were admitted as inpatients to intensive care units,
general medical, surgical, extended care and psychiatric ⁄ sub-
stance abuse units; (2) reported using tobacco within 1 month
prior to hospitalization; (3) had a projected hospital stay of at
least 24 h; and (4) were willing to complete a written 15-min
survey prior to discharge. Patientswere excluded if they: (1)were
considered by their inpatient team to be too ill to participate; (2)
were terminally ill; (3) were involved in a concurrent trial that
included intervention on smoking; or (4) were pregnant.
Of the 907 tobacco users approached to participate between
1 May 2006 and 18 September 2009, 73 were either ineligible,
did not complete the baseline survey or died prior to the
6-month follow up date. In addition, 26 patients were sent a
6-month survey, but died before it could be returned. Of the
808 remaining, 312 did not complete the follow-up survey and
were thus classified as non-responders. The remaining 496 were
included in this sample. Patients that did not return a 6-month
survey were more likely to have cancer, but less likely to have
psychiatric problems, arthritis or alcohol problems (P < 0.05).
The overall survey response rate was 61% (496 ⁄808) and was
roughly equivalent among patients with and without diabetes.
Procedures
Tobacco users were identified soon after admission using the
nursing assessment in the Department of Veterans Affairs
electronic medical record, the Computerized Patient Record
System. Identified patients were approached by a research
assistant who obtained informed consent and completed the
baseline survey with the patient. A second survey was mailed to
participants 6 months post-discharge. At 6 months, partici-
pants also were asked to return a urine cotinine strip to confirm
6-month smoking status. Participants were given $5.00 for
completing each survey and $15.00 for returning a cotinine test.
Measures
Co-morbidities
Co-morbidities were measured using both self-report and
electronic medical record data. Using a validated instrument
[12] patients were asked (yes ⁄no) if they had ever been diag-
nosed with diabetes, psychiatric problems, cancer, lung disease,
heart disease, high blood pressure, stroke or arthritis ⁄ortho-
paedic problems. Patients who had diabetes or other chronic
conditions of interest self-reported or were listed as an Inter-
national Classification of Diseases-9 coded diagnosis in inpa-
tient or outpatient encounters were considered to have that
diagnosis. Patients could have more than one co-morbid
condition. The correlation between self-reported and medical
record-abstracted diabetes diagnosis was 0.86.
Problem drinking was assessed using the Alcohol Use
Disorders Identification Test (AUDIT) [13]. An AUDIT score
‡ 8 was considered problem drinking. Depressive symptoms
were measured using the Geriatric Depression Scale Short Form
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(GDS) [14]. A GDS score ‡ 4 was considered as having
depressive symptoms. Self-rated health was measured by the
validated question ‘In general, would you say your health is
excellent ⁄very good ⁄good ⁄ fair ⁄poor?’ [15].
Tobacco use
The six-question Fagerstrom Test for Nicotine Dependence
(FTND) was used to assess nicotine dependence at the time of
hospitalization [16]. A FTND score ‡ 6 was considered
nicotine dependent. Outcomes included self-reported 6-month
cessation rates and 6-month cotinine-verified tobacco cessation.
Patients were asked a validated question to measure self-
reported 6-month tobacco cessation [17]: ‘Have you used any
tobacco products in the past 7 days (yes ⁄no)?’ This question
was also confirmed with a urinary cotinine level screen. The 57
patients that did not return a cotinine test strip or that had an
unreadable result were counted in the cotinine-verified patients
who had not stopped smoking.
Demographics
Demographic factors that have been found to influence tobacco
cessation were collected via baseline survey and electronic
records, including age, sex, race ⁄ ethnicity, marital status,
education and employment. For the bivariate- and multivari-
able-adjusted analyses, race was classified as white vs. non-
white, marital status was classified as married vs. not married,
education was classified as high school or less vs. some college
or more, and employment was classified as employed vs. not
employed.
Data analysis
Means and frequencies were calculated for all variables. The
primary independent variable of interest was diagnosis with
diabetes (yes ⁄no). Dependent variables included measures of
6-month tobacco cessation rates (i.e. 6-month self-reported and
cotinine-verified cessation rates). Bivariate analyses were
conducted using v2-, Fisher’s exact or Student’s t-tests to test
differences between patients with and without diabetes in
6-month tobacco cessation, nicotine dependence, problem
drinking, depressive symptoms, co-morbid chronic illnesses and
demographic characteristics. Covariates significantly associated
with the 6-month cessation indicators or with co-morbid
diabetes status in bivariate analyses were considered for inclu-
sion as control variables in the multivariable-adjusted analysis.
Multivariable-adjusted logistic regression models were used
to determine the independent association between diabetes
diagnosis and the tobacco cessation variables. Variables with
statistically significant bivariate relationships with the outcome
measures and ⁄or with the main predictor of interest were
considered for inclusion in the final model. Final model selec-
tion was based on reported importance of variables in the
literature, model fit and control of confounding.
Collinearity diagnostics, including variance inflation factors,
were examined to ensure that there was not collinearity
between predictor variables in the final models. Importantly,
the variance inflation factor for co-morbid psychiatric problems
and depression was only 1.084 and indicated low multicollin-
earity between these two variables.
Missing data were handled using case-wise deletion. Patients
with missing data were not different in terms of key variables of
interest, including cessation outcomes or co-morbid diabetes.
Most variables did not have any missing data. Of the variables
included in the multi-variable adjusted logistic regression
models, 36 patients (7%) had depression data missing, 42
patients (8%) had nicotine-dependence data missing and 18
patients (4%) had self-rated health data missing. Values for
P < 0.05 are reported.
Results
Patient baseline characteristics
The average age of patients was 55.2 years, most of the
patients were male and the majority (62%) were white
(Table 1). Approximately one quarter were married, just over
half had some college education or more and only 15% were
employed. Approximately one third of the patients had
co-morbid diabetes (29.0%, n = 144). Of the other co-mor-
bidities, the most common was high blood pressure, followed
by psychiatric problems, arthritis, heart disease, lung disease,
cancer and stroke (Table 1). The most common reasons for
being admitted to the hospital were for psychiatric problems or
surgery. Approximately one third (32%, n = 152) of patients
screened positive for alcohol problems and over half (60%,
n = 276) screened positive for depressive symptoms. Over half
of patients (59%) self-reported their health status as fair or
poor; only 13% of patients reported their health status as
excellent or very good.
Compared with patients without diabetes, patients with
diabetes were approximately 3.5 years older (P = 0.0003),
were more likely to report poorer health (P = 0.02) and were
less likely to have psychiatric co-morbidities (P = 0.009).
Patients with diabetes also were more likely to have co-morbid
lung disease, heart disease, high blood pressure and stroke
(P < 0.05) and were more likely to be admitted to the hospital
for heart disease, wound healing or vascular problems
(P < 0.05). However, those with diabetes were less likely to be
admitted to the hospital for cancer or psychiatric problems
(P < 0.05) and were less likely to have depressive symptoms
(P = 0.004) and problem alcohol use (P = 0.0008).
Baseline tobacco use
While most of the tobacco users were smokers, nine (2%) were
smokeless tobacco users. Among the smokers, 43% were
considered nicotine dependent, as defined by a Fagerstrom
score ‡ 6 [16]. On average, patients smoked nearly one pack
(equivalent to 20 cigarettes) per day in the month prior to their
baseline admission. Nicotine dependence did not differ signifi-
cantly at baseline between patients with and without diabetes.
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Six-month cessation rates
The 6-month self-reported cessation rate was 13.2% (n = 65)
and the cotinine-verified 6-month cessation rate was 8.9%
(n = 44). In bivariate analyses, the 6-month self-reported
cessation rates among patients with diabetes (18.8%) was sig-
nificantly higher than among patients without diabetes (10.9%,
P = 0.02). The cotinine-verified cessation rate was also was
higher in the subgroup with diabetes compared with the







vs. no diabetesMean sd Mean sd Mean sd
Age 55.2 9.2 57.5 7.6 54.2 9.6 < 0.0001
Number of cigarettes smoked
per day in past month
18.4 12.9 18.0 14.1 18.6 12.4 0.63
n % n % n %
Sex
Male 470 94.8 135 93.8 335 95.2 0.52
Female 26 5.2 9 6.3 17 4.8
Race ⁄ ethnicity
White 307 62.2 87 60.4 220 62.9 0.61
Non-white 187 37.9 57 39.6 130 37.1
Marital status
Married 115 23.2 41 28.5 74 21.1 0.08
Not married 380 76.8 103 71.5 277 78.9
Education status
High school or less 209 42.6 58 40.3 151 43.5 0.51
Some college or more 282 57.4 86 59.7 196 56.5
Employment status
Employed 71 15.5 17 12.7 54 16.6 0.29
Not employed 388 84.5 117 87.3 271 83.4
Co-morbidities
High blood pressure 337 67.9 131 91.0 206 58.5 < 0.0001
Psychiatric problems 306 61.7 76 52.8 230 65.3 0.009
Arthritis 286 57.7 84 58.3 202 57.4 0.85
Heart disease 192 38.7 76 52.8 116 33.0 < 0.0001
Lung disease 176 35.5 61 42.4 115 32.7 0.04
Cancer 79 15.9 18 12.5 61 17.3 0.18
Stroke 62 12.5 26 18.1 36 10.2 0.02
2 or more co-morbidities 370 74.6 139 96.5 231 65.6 < 0.0001
Reasons admitted to hospital
Cancer 36 7.3 5 3.5 31 8.8 0.04
Lung disease 47 9.5 17 11.8 30 8.5 0.26
Heart disease 86 17.3 36 25.0 50 14.2 0.004
Stroke 22 4.4 9 6.3 13 3.7 0.21
Psychiatric problems 140 28.2 28 19.4 112 31.8 0.006
Arthritis 39 7.9 11 7.6 28 8.0 0.91
Wound healing 30 6.1 15 10.4 15 4.3 0.009
Surgery 118 23.8 31 21.5 87 24.7 0.45
Vascular problems 44 8.9 19 13.2 25 7.1 0.03
Problem alcohol (AUDIT ‡ 8) 152 32.1 29 20.9 123 36.7 0.0008
Depressive symptoms (GDS ‡ 4) 276 60.0 66 48.5 210 64.8 0.001
Self-rated health status
Excellent 10 2.1 3 2.1 7 2.1 0.02
Very good 53 11.1 9 6.4 44 13.1
Good 135 28.2 31 22.0 104 30.9
Fair 179 37.5 66 46.8 113 33.5
Poor 101 21.1 32 22.7 69 20.5
Nicotine dependent (FTND ‡ 6) 196 43.2 54 42.9 142 43.3 0.93
Self-reported 6-month cessation rate 65 13.2 27 18.8 38 10.9 0.02
Cotinine-verified 6-month cessation rate 44 8.9 18 12.5 26 7.4 0.07
AUDIT, Alcohol Use Disorders Identification Test; FTND, Fagerstrom Test for Nicotine Dependence; GDS, Geriatric Depression Scale Short
Form.
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subgroup without diabetes (12.5 vs. 7.4%, respectively) and
this was marginally statistically significant (P = 0.07). Six-
month self-reported and cotinine-verified cessation rates were
lower among patients with psychiatric co-morbidities (10.5 and
5.9%) as compared with those without psychiatric problems
(17.6 and 13.7%; P = 0.03 and P = 0.003, respectively).
Likewise, those with depressive symptoms had lower self-
reported cessation rates (11.0%) as compared with those
without depressive symptoms (16.4%, P = 0.09). Patients who
were nicotine dependent at baseline had lower 6-month self-
reported and cotinine-verified cessation as compared with those
that were not nicotine dependent.
Multivariable-adjusted analyses
Diabetes status was statistically significantly associated with
self-reported 6-month tobacco cessation in an unadjusted
model, whereas the relationship between cotinine-verified
6-month tobacco cessation and diabetes status was marginally
significant. However, as shown in Table 2, after adjustment for
psychiatric co-morbidities, depressive symptoms, age, self-rated
health and nicotine dependence, there was a statistically sig-
nificant relationship between diabetes status and both outcome
variables (P < 0.01). Specifically, patients with diabetes had
more than two and a half times greater odds of self-reported
cessation at 6 months compared with those without diabetes
(odds ratio 2.65, P = 0.003). Moreover, those with diabetes
had more than three times greater odds of cotinine-verified
6-month cessation compared with those without diabetes (odds
ratio 3.17, P = 0.005). Psychiatric co-morbidities, depressive
symptoms, age and nicotine dependence at baseline were not
independently associated with any of the outcomes in the
multivariable analysis.
Discussion
Despite similar levels of baseline nicotine dependence, patients
with diabetes had substantially higher tobacco cessation rates
6 months after hospitalization compared with patients with
other diagnoses. Given the serious consequences of tobacco use
for the cardiovascular risk profile of patients with diabetes,
these findings are encouraging. The reason for these higher
cessation rates are unclear, but may be related to a variety of
factors, such as multiple co-morbidities, higher motivation to
stop because of diabetic complications caused by smoking and
frequent hospitalizations among those with diabetes. In fact,
29% of the hospitalized tobacco users had diabetes compared
with 20% of Department of Veterans Affairs users and 8% of
the general population that have diabetes [1], suggesting high
hospitalization rates among smokers with diabetes.
While these results indicate that hospitalized patients with
diabetes have higher cessation rates than those without diabe-
tes, the majority of hospitalized patients with diabetes still
failed to achieve cessation 6 months post-discharge and
therefore remain at substantially higher risk for myocardial
infarctions, stroke, renal failure and cancer. A prior study
conducted in these same hospitals by our group found that only
17% of inpatient smokers reported receiving smoking cessation
interventions [18]. Introducing state-of-the-art inpatient
smoking cessation interventions are likely to enhance the
already elevated cessation rates among patients with diabetes
who are frequently hospitalized. Smoking cessation interven-
tions (both pharmacotherapy and behavioural intervention
followed by supportive contacts after discharge) that begin
during hospitalization increase the odds of smoking cessation
by 65% at 6–12 months over what is achieved after usual
hospital care [10], particularly among motivated smokers.
Limitations of the study
The study included only tobacco users hospitalized in the
Department of Veterans Affairs and therefore may not gener-
alize to other populations. The response rate was only 61%;
not all of the patients returned cotinine urine strips and those
patients’ cessation rates may have been different. Six-month
follow-up data was obtained by post, whereas face-to-face
communication may have been more reliable. Although the
concordance between self-report and urinary cotinine status
has been shown to be high [19,20], use of nicotine replacement
therapy was not assessed, which could affect urinary cotinine
levels. The outcome measure was 7-day point prevalence
abstinence at 6 months post-discharge and not continuous
Table 2 Multivariable-adjusted logistic regression: co-morbid diabetes status and self-reported or cotinine-verified 6-month cessation rates
6-month self-report cessation
(n = 65 stopped smoking)
Verified 6-month cessation
(n = 44 stopped smoking)
Odds ratio 95% CI P-value Odds ratio 95% CI P-value
Co-morbid diabetes 2.65 1.38–5.09 0.003 3.17 1.41–7.15 0.005
Co-morbid psychiatric problems 0.81 0.41–1.57 0.52 0.65 0.28–1.50 0.31
Depressive symptoms 0.82 0.42–1.60 0.55 1.26 0.54–2.98 0.59
Self-rated health 0.86 0.63–1.18 0.36 0.65 0.44–0.97 0.03
Nicotine dependence 0.58 0.30–1.14 0.11 0.54 0.23–1.30 0.17
Age 0.99 0.95–1.02 0.44 1.02 0.97–1.06 0.48
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abstinence after hospitalization. While there were a large
number of African Americans included in the study, similar to
the Midwest region of the three study sites, Hispanics and other
minorities were less represented.
Conclusions
Tobacco cessation rates 6 months after hospitalization were
higher among hospitalized patients with diabetes than among
those without diabetes. The results indicate that the event of
hospitalization may present an opportunity for tobacco users
with diabetes to stop smoking. Intensive tobacco cessation
intervention strategies for inpatient smokers with diabetes are
likely to further enhance cessation rates and decrease morbidity
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